Magnesium Verla (Magnesium Oxide, Heavy, Magnesium Citrate Dibasic)

Magnesium Verla is used to address conditions related to low magnesium levels and associated electrolyte disturbances.

• Magnesium deficiency: restores normal magnesium concentrations and supports metabolic functions.
• Hypomagnesemia: raises serum magnesium to therapeutic range and alleviates related symptoms.
• Electrolyte imbalance: contributes to overall electrolyte homeostasis when magnesium is a limiting factor.

• Magnesium Verla supplies magnesium ions that are readily absorbed in the gastrointestinal tract. Once in circulation, magnesium acts as a co‑factor for numerous enzymes involved in ATP synthesis, protein formation and nucleic acid stability. It also participates in regulation of ion channels, influencing calcium and potassium transport, and helps maintain neuromuscular and cardiac excitability. By replenishing intracellular magnesium stores, the supplement corrects deficiency‑related metabolic disruptions.

Magnesium Verla may cause adverse reactions, most of which are mild and transient.

Common Side Effects

• Diarrhea: loose stools occurring after oral intake.
• Abdominal cramping: discomfort in the stomach region.
• Nausea: feeling of sickness or urge to vomit.
• Flatulence: increased intestinal gas.
• Metallic taste: temporary alteration in taste perception.

Serious or Rare Side Effects

• Hypermagnesemia: elevated serum magnesium leading to muscle weakness, low blood pressure, or cardiac arrhythmia.
• Severe hypotension: marked drop in blood pressure requiring medical attention.
• Respiratory depression: slowed breathing in extreme cases.
• Cardiac conduction abnormalities: irregular heart rhythm such as AV block.
• Allergic reaction: rash, itching, swelling, or anaphylaxis.

When prescribing Magnesium Verla, clinicians should consider several safety measures.

• Renal function assessment: evaluate kidney performance before initiating therapy.
• Serum magnesium monitoring: check levels periodically to avoid excess.
• Dose adjustment in elderly: reduce dose if frailty or reduced clearance is present.
• Contraindication in known hypersensitivity: discontinue if allergic signs appear.
• Caution with cardiac conduction disorders: monitor ECG when high doses are used.
• Store at room temperature: keep in original container, protect from moisture and direct sunlight.

Magnesium Verla can affect the absorption or activity of several medicines.

Major Interactions (Avoid)

• Potassium‑sparing diuretics (e.g., spironolactone): risk of additive hypermagnesemia.
• Neuromuscular blocking agents (e.g., succinylcholine): potentiation of muscle relaxation.

Moderate Interactions (Monitor Closely)

• Tetracycline antibiotics: magnesium chelation reduces antibiotic absorption.
• Fluoroquinolone antibiotics: concurrent use may diminish fluoroquinolone bioavailability.
• Bisphosphonates: magnesium may interfere with oral bisphosphonate absorption.
• Proton pump inhibitors: long‑term use may exacerbate magnesium depletion, requiring monitoring.